TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women
Brief Summary: The purpose of this study to assess the safety of the etonogestrel-releasing subdermal implant (Implanon) inserted during the immediate puerperium of healthy women.


Options:
A: Arm Label: Counseling for LAM; Type: ACTIVE_COMPARATOR; Interventions: Drug: Counseling for LAM+ LNG-EC | Arm Label: Counseling for LAM+ LNG-EC; Type: EXPERIMENTAL; Interventions: Drug: Counseling for LAM+ LNG-EC | Intervention Type: DRUG; Name: Counseling for LAM+ LNG-EC; Assigned to Arm(s): Counseling for LAM, Counseling for LAM+ LNG-EC
B: Arm Label: Postplacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Arm Label: Delayed IUD insertion; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing IUD (Mirena); Assigned to Arm(s): Delayed IUD insertion, Postplacental IUD insertion
C: Arm Label: Combined oral contraceptive; Type: ACTIVE_COMPARATOR; Interventions: Drug: 30 mcg EE and 150 LNG oral contraceptive (Microvlar), Device: TCu380A intrauterine device | Arm Label: Levonorgestrel intrauterine system; Type: ACTIVE_COMPARATOR; Interventions: Device: LNG-IUS, Device: TCu380A intrauterine device | Arm Label: Implanon; Type: ACTIVE_COMPARATOR; Interventions: Device: Implanon, Device: TCu380A intrauterine device | Arm Label: TCu380A intrauterine device; Type: ACTIVE_COMPARATOR; Interventions: Device: TCu380A copper-intrauterine device, Device: TCu380A intrauterine device | Intervention Type: DEVICE; Name: LNG-IUS; Assigned to Arm(s): Levonorgestrel intrauterine system | Intervention Type: DEVICE; Name: Implanon; Assigned to Arm(s): Implanon | Intervention Type: DRUG; Name: 30 mcg EE and 150 LNG oral contraceptive (Microvlar); Assigned to Arm(s): Combined oral contraceptive | Intervention Type: DEVICE; Name: TCu380A copper-intrauterine device; Assigned to Arm(s): TCu380A intrauterine device | Intervention Type: DEVICE; Name: TCu380A intrauterine device; Assigned to Arm(s): Combined oral contraceptive, Implanon, Levonorgestrel intrauterine system, TCu380A intrauterine device
D: Arm Label: etonogestrel implant; Type: EXPERIMENTAL; Interventions: Drug: etonogestrel implant | Arm Label: depot medroxyprogesterone acetate; Type: ACTIVE_COMPARATOR; Interventions: Drug: depot medroxyprogesterone acetate | Intervention Type: DRUG; Name: etonogestrel implant; Assigned to Arm(s): etonogestrel implant | Intervention Type: DRUG; Name: depot medroxyprogesterone acetate; Assigned to Arm(s): depot medroxyprogesterone acetate

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IV Prospective, Multicenter, Randomized, Open-label Trial to Assess the Efficacy and Safety of GONAL f® at a Dose Based on Subject Baseline Characteristics Determined According to the CONSORT Calculator Compared With a Standard Dose of GONAL f® 150 IU Per Day for Ovarian Stimulation in Women Undergoing Assisted Reproductive Technology (ART)
Brief Summary: The overall objective of this trial is to compare the ovarian response in assisted reproductive technology (ART) subjects administered GONAL f® according to the 'Consistency in recombinant follicle stimulating hormone \[r-FSH\] starting doses for individualized treatment' (CONSORT) calculator versus given a standard GONAL f® dose of 150 International Unit (IU) per day.


Options:
A: Arm Label: Follitropin delta; Type: EXPERIMENTAL; Interventions: Drug: Follitropin delta | Arm Label: Gonal-F; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin alfa | Intervention Type: DRUG; Name: Follitropin alfa; Assigned to Arm(s): Gonal-F | Intervention Type: DRUG; Name: Follitropin delta; Assigned to Arm(s): Follitropin delta
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Patients receiving short protocol IVF/ICSI-treatment. | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Long protocol | Intervention Type: DRUG; Name: Patients receiving short protocol IVF/ICSI-treatment.; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Long protocol; Assigned to Arm(s): 2
C: Arm Label: AMH-group; Type: EXPERIMENTAL; Interventions: Other: AMH-analysis | Arm Label: Non-AMH-group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: AMH-analysis; Assigned to Arm(s): AMH-group
D: Arm Label: CONSORT Dosing; Type: EXPERIMENTAL; Interventions: Drug: GONAL f® prefilled pen | Arm Label: Standard Dosing; Type: ACTIVE_COMPARATOR; Interventions: Drug: GONAL f® prefilled pen | Intervention Type: DRUG; Name: GONAL f® prefilled pen; Assigned to Arm(s): CONSORT Dosing | Intervention Type: DRUG; Name: GONAL f® prefilled pen; Assigned to Arm(s): Standard Dosing

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IV Prospective, Multicenter, Randomized, Open-label Trial to Assess the Efficacy and Safety of GONAL f® at a Dose Based on Subject Baseline Characteristics Determined According to the CONSORT Calculator Compared With a Standard Dose of GONAL f® 150 IU Per Day for Ovarian Stimulation in Women Undergoing Assisted Reproductive Technology (ART)
Brief Summary: The overall objective of this trial is to compare the ovarian response in assisted reproductive technology (ART) subjects administered GONAL f® according to the 'Consistency in recombinant follicle stimulating hormone \[r-FSH\] starting doses for individualized treatment' (CONSORT) calculator versus given a standard GONAL f® dose of 150 International Unit (IU) per day.


Options:
A: Arm Label: AMH-group; Type: EXPERIMENTAL; Interventions: Other: AMH-analysis | Arm Label: Non-AMH-group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: AMH-analysis; Assigned to Arm(s): AMH-group
B: Arm Label: CONSORT Dosing; Type: EXPERIMENTAL; Interventions: Drug: GONAL f® prefilled pen | Arm Label: Standard Dosing; Type: ACTIVE_COMPARATOR; Interventions: Drug: GONAL f® prefilled pen | Intervention Type: DRUG; Name: GONAL f® prefilled pen; Assigned to Arm(s): CONSORT Dosing | Intervention Type: DRUG; Name: GONAL f® prefilled pen; Assigned to Arm(s): Standard Dosing
C: Arm Label: 5.2 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 6.9 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 8.6 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 10.3 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 12.1 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 11 µg FbM (150 IU); Type: ACTIVE_COMPARATOR; Interventions: Drug: Gonal - F | Intervention Type: DRUG; Name: FE 999049; Assigned to Arm(s): 10.3 µg, 12.1 µg, 5.2 µg, 6.9 µg, 8.6 µg | Intervention Type: DRUG; Name: Gonal - F; Assigned to Arm(s): 11 µg FbM (150 IU)
D: Arm Label: 450 IU daily dose of gonadotrophin; Type: ACTIVE_COMPARATOR; Interventions: Drug: menotropins for injection, Drug: urofollitropin for injection | Arm Label: 600 IU daily dose of gonadotrophin; Type: EXPERIMENTAL; Interventions: Drug: menotropins for injection, Drug: urofollitropin for injection | Intervention Type: DRUG; Name: menotropins for injection; Assigned to Arm(s): 450 IU daily dose of gonadotrophin, 600 IU daily dose of gonadotrophin | Intervention Type: DRUG; Name: urofollitropin for injection; Assigned to Arm(s): 450 IU daily dose of gonadotrophin, 600 IU daily dose of gonadotrophin

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stroke Telemedicine for Arizona Rural Residents Trial
Brief Summary: The STARR network registry consists of a 4 spoke 1 hub system. Which will consist of prospective collection, recording, and regular analysis of telestroke patient consultation and care data for the purpose of quality measure assessment and improvement and benchmarking against other national and international telestroke programs.


Options:
A: Arm Label: Arm 1; Type: OTHER; Interventions: Behavioral: Telephone behavioral education, Behavioral: Computer behavioral education | Intervention Type: BEHAVIORAL; Name: Telephone behavioral education; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Computer behavioral education; Assigned to Arm(s): Arm 1
B: Arm Label: Telemedicine; Type: OTHER; Interventions: Other: Telemedicine | Intervention Type: OTHER; Name: Telemedicine; Assigned to Arm(s): Telemedicine
C: Arm Label: Videoteleconferencing AMT; Type: EXPERIMENTAL; Interventions: Behavioral: 12 sessions Anger Management Therapy. | Arm Label: Face to Face AMT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12 sessions Anger Management Therapy. | Intervention Type: BEHAVIORAL; Name: 12 sessions Anger Management Therapy.; Assigned to Arm(s): Face to Face AMT, Videoteleconferencing AMT
D: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Use of PDA + support to reduce weight and pain | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: MOVE! level 2 group weight loss counseling | Intervention Type: BEHAVIORAL; Name: Use of PDA + support to reduce weight and pain; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: MOVE! level 2 group weight loss counseling; Assigned to Arm(s): Arm 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cognitive Training to Enhance VA Work Program Outcomes
Brief Summary: The purpose of this study is to determine whether augmenting work services with cognitive remediation can improve vocational outcomes for psychiatrically disabled participants in VA work services.


Options:
A: Arm Label: Physical activity; Type: EXPERIMENTAL; Interventions: Other: Physical activity | Arm Label: Computer game skills training; Type: ACTIVE_COMPARATOR; Interventions: Other: Computer game skills training | Intervention Type: OTHER; Name: Computer game skills training; Assigned to Arm(s): Computer game skills training | Intervention Type: OTHER; Name: Physical activity; Assigned to Arm(s): Physical activity
B: Arm Label: Experimental Treatment; Type: EXPERIMENTAL; Interventions: Other: Computerized plasticity-based adaptive cognitive training | Arm Label: Active Comparator; Type: ACTIVE_COMPARATOR; Interventions: Other: Commercially available computerized training | Intervention Type: OTHER; Name: Computerized plasticity-based adaptive cognitive training; Assigned to Arm(s): Experimental Treatment | Intervention Type: OTHER; Name: Commercially available computerized training; Assigned to Arm(s): Active Comparator
C: Arm Label: Posit Science; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Remediation | Arm Label: Nintendo Brain Age; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nintendo Brain Age | Intervention Type: BEHAVIORAL; Name: Cognitive Remediation; Assigned to Arm(s): Posit Science | Intervention Type: BEHAVIORAL; Name: Nintendo Brain Age; Assigned to Arm(s): Nintendo Brain Age
D: Arm Label: Aerobic Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Aerobic Exercise | Arm Label: Standard Psychiatric Treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Psychiatric Treatment | Intervention Type: BEHAVIORAL; Name: Aerobic Exercise; Assigned to Arm(s): Aerobic Exercise | Intervention Type: OTHER; Name: Standard Psychiatric Treatment; Assigned to Arm(s): Standard Psychiatric Treatment

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Oral Hygiene With 0.12% Chlorhexidine Antiseptic Solution on the Incidence of Nosocomial Pneumonia and Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery
Brief Summary: Hospital infections play an important role in the increase of patients' morbimortality and hospitalization costs, especially in the case of individuals admitted to intensive care units (ICU) during postoperative heart surgery. Analysis of the epidemiological profile of the hospital infections in the pediatric-ICU (P-ICU) of Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, University of São Paulo (HCFMRP-USP) demonstrated a 31.1% incidence of pneumonia (PNM) and a rate of ventilator-associated pneumonia (VAP) of 23.81 per 1000 ventilators-day between March 2004 and February 2005 in the group submitted to cardiac surgery. Knowledge of the pathophysiology and risk factors associated with this infection allows for measures aiming at reducing its incidence. The objective of the present study is to evaluate the effect of oral hygiene with a 0.12% chlorhexidine solution on the incidence of PNM and PAV in children submitted to cardiac surgery.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Oral Care | Arm Label: B; Type: EXPERIMENTAL; Interventions: Procedure: Comprehensive Oral Care | Intervention Type: PROCEDURE; Name: Standard Oral Care; Assigned to Arm(s): A | Intervention Type: PROCEDURE; Name: Comprehensive Oral Care; Assigned to Arm(s): B
B: Arm Label: 0.12% Chlorhexidie Digluconate; Type: EXPERIMENTAL; Interventions: Drug: 0.12% Chlorhexidine Digluconate | Arm Label: Toothbrushing; Type: PLACEBO_COMPARATOR; Interventions: Other: Toothbrushing | Intervention Type: DRUG; Name: 0.12% Chlorhexidine Digluconate; Assigned to Arm(s): 0.12% Chlorhexidie Digluconate | Intervention Type: OTHER; Name: Toothbrushing; Assigned to Arm(s): Toothbrushing
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: oral hygiene | Intervention Type: OTHER; Name: oral hygiene; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): 1
D: Arm Label: Oral Chlorhexidine Mouth Rinse; Type: OTHER; Interventions: Other: Chlorhexidine Mouth Rinse | Arm Label: De-Adoption of Oral Chlorhexidine Mouth Rinse; Type: EXPERIMENTAL; Interventions: Other: Chlorhexidine Mouth Rinse De-Adoption | Intervention Type: OTHER; Name: Chlorhexidine Mouth Rinse; Assigned to Arm(s): Oral Chlorhexidine Mouth Rinse | Intervention Type: OTHER; Name: Chlorhexidine Mouth Rinse De-Adoption; Assigned to Arm(s): De-Adoption of Oral Chlorhexidine Mouth Rinse

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Oral Hygiene With 0.12% Chlorhexidine Antiseptic Solution on the Incidence of Nosocomial Pneumonia and Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery
Brief Summary: Hospital infections play an important role in the increase of patients' morbimortality and hospitalization costs, especially in the case of individuals admitted to intensive care units (ICU) during postoperative heart surgery. Analysis of the epidemiological profile of the hospital infections in the pediatric-ICU (P-ICU) of Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, University of São Paulo (HCFMRP-USP) demonstrated a 31.1% incidence of pneumonia (PNM) and a rate of ventilator-associated pneumonia (VAP) of 23.81 per 1000 ventilators-day between March 2004 and February 2005 in the group submitted to cardiac surgery. Knowledge of the pathophysiology and risk factors associated with this infection allows for measures aiming at reducing its incidence. The objective of the present study is to evaluate the effect of oral hygiene with a 0.12% chlorhexidine solution on the incidence of PNM and PAV in children submitted to cardiac surgery.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Oral Care | Arm Label: B; Type: EXPERIMENTAL; Interventions: Procedure: Comprehensive Oral Care | Intervention Type: PROCEDURE; Name: Standard Oral Care; Assigned to Arm(s): A | Intervention Type: PROCEDURE; Name: Comprehensive Oral Care; Assigned to Arm(s): B
B: Arm Label: Raspall; Type: EXPERIMENTAL; Interventions: Procedure: Toothbrushing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Toothbrushing; Assigned to Arm(s): Raspall
C: Intervention Type: DRUG; Name: Chlorhexidine gluconate (drug) vs placebo; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: oral hygiene | Intervention Type: OTHER; Name: oral hygiene; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin（CI-1008）In The Treatment Of Fibromyalgia
Brief Summary: This study, will compare pregabalin with placebo for the duration of 15 weeks to evaluate the efficacy and safety of pregabalin in patients with fibromyalgia.


Options:
A: Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): N/A
B: Arm Label: Lyrica; Type: EXPERIMENTAL; Interventions: Drug: Pregabalin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Lyrica | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Pregabalin; Type: EXPERIMENTAL; Interventions: Drug: Pregabalin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Pregabalin
D: Arm Label: Pregabalin; Type: EXPERIMENTAL; Interventions: Drug: Pregabalin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Pregabalin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Carotid Stent Design on Cerebral Embolization
Brief Summary: The goal of the proposed study is to contrast the relative efficacy of closed-cell stents versus open-cell stents in preventing periprocedural cerebral embolization in high-risk patients with symptomatic and asymptomatic extracranial carotid stenosis undergoing carotid artery stenting (CAS).


Options:
A: Intervention Type: DEVICE; Name: Cordis Nitinol Stent; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: PRECISE tapered stent; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: ANGIOGUARD XP Emboli Capture Guidewire (ECGW); Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Carotid angioplasty and stenting with cerebral protection | Intervention Type: DEVICE; Name: Carotid angioplasty and stenting with cerebral protection; Assigned to Arm(s): 1
C: Arm Label: Closed-cell stent (Xact stent); Type: ACTIVE_COMPARATOR; Interventions: Device: closed-cell stent (Xact stent) | Arm Label: Open-cell stent (Acculink carotid); Type: ACTIVE_COMPARATOR; Interventions: Device: Open-cell stent (Acculink carotid) | Intervention Type: DEVICE; Name: closed-cell stent (Xact stent); Assigned to Arm(s): Closed-cell stent (Xact stent) | Intervention Type: DEVICE; Name: Open-cell stent (Acculink carotid); Assigned to Arm(s): Open-cell stent (Acculink carotid)
D: Arm Label: MICHI NPS+f; Type: EXPERIMENTAL; Interventions: Device: MICHI NPS+f | Intervention Type: DEVICE; Name: MICHI NPS+f; Assigned to Arm(s): MICHI NPS+f

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Targeted Cell Phone Intervention to Improve Patient Access to Care and Drug Adherence in Patients Taking Antiretroviral (ARV) Medications in Kenya
Brief Summary: A clinical study to evaluate the use of cell phones to support drug adherence and follow-up of patients taking antiretroviral therapy (ART) for treatment of HIV. The intervention involves health-care providers sending regular short-message-service (SMS) text messages to patients and following up their responses. The hypothesis is that the cell phone intervention will improve ART adherence and health outcomes compared with the current standard of care.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Cell Phone Intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cell Phone Intervention; Assigned to Arm(s): 1
B: Arm Label: Usual care (UC); Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Arm Label: Self-management; Type: EXPERIMENTAL; Interventions: Device: Self-management | Arm Label: PCTM intervention; Type: EXPERIMENTAL; Interventions: Other: PCTM intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care (UC) | Intervention Type: DEVICE; Name: Self-management; Assigned to Arm(s): Self-management | Intervention Type: OTHER; Name: PCTM intervention; Assigned to Arm(s): PCTM intervention
C: Arm Label: Stay Strong w/coaching; Type: EXPERIMENTAL; Interventions: Behavioral: Stay Strong w/coaching | Arm Label: Stay Strong; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stay Strong | Intervention Type: BEHAVIORAL; Name: Stay Strong w/coaching; Assigned to Arm(s): Stay Strong w/coaching | Intervention Type: BEHAVIORAL; Name: Stay Strong; Assigned to Arm(s): Stay Strong
D: Arm Label: mWELLCARE software arm; Type: EXPERIMENTAL; Interventions: Other: mWELLCARE | Arm Label: Usual care arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: mWELLCARE; Assigned to Arm(s): mWELLCARE software arm | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual care arm

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Targeted Cell Phone Intervention to Improve Patient Access to Care and Drug Adherence in Patients Taking Antiretroviral (ARV) Medications in Kenya
Brief Summary: A clinical study to evaluate the use of cell phones to support drug adherence and follow-up of patients taking antiretroviral therapy (ART) for treatment of HIV. The intervention involves health-care providers sending regular short-message-service (SMS) text messages to patients and following up their responses. The hypothesis is that the cell phone intervention will improve ART adherence and health outcomes compared with the current standard of care.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Cell Phone Intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cell Phone Intervention; Assigned to Arm(s): 1
B: Arm Label: All practices; Type: OTHER; Interventions: Behavioral: DQIP Intervention | Intervention Type: BEHAVIORAL; Name: DQIP Intervention; Assigned to Arm(s): All practices
C: Arm Label: Intervention group; Type: N/A; Interventions: Other: e-Chasqui | Arm Label: Simultaneous/historical control group; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: e-Chasqui; Assigned to Arm(s): Intervention group
D: Arm Label: A - coded unit ID; Type: EXPERIMENTAL; Interventions: Other: clinical decision support | Arm Label: B - coded unit ID; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: clinical decision support; Assigned to Arm(s): A - coded unit ID

Answer: A